About the company
For over a quarter-century, Xstrahl has been a pivotal force in the med-tech sector, engineering sophisticated radiation delivery systems. Their technology serves a dual purpose: empowering clinical practitioners in patient care and providing cancer researchers with the tools necessary for groundbreaking discoveries.
Why Xstrahl Leads the Field:
- Decades of Innovation: With a legacy spanning more than 25 years, the company has been instrumental in evolving orthovoltage and superficial radiotherapy techniques.
- Scientific Progress: Beyond clinical application, Xstrahl is a primary driver in the advancement of preclinical radiation studies.
- Global Presence: Today, their specialized systems are utilized in over 700 prestigious research institutions and treatment centers across the globe.
By bridging the gap between theoretical research and clinical practice, Xstrahl continues to refine how radiation is applied in the fight against cancer.
What is orthovoltage and superficial radiotherapy?
Superficial (SRT) and orthovoltage radiotherapy are low-energy, office-based x-ray treatments targeting non-melanoma skin cancers (BCC, SCC) and benign conditions like keloids. They offer a non-surgical, painless option, with SRT treating surface lesions (40–150 kV) and orthovoltage (150–500 kV) penetrating up to 5 cm, often leaving minimal to no scarring
Key Differences & Characteristics
- Superficial Therapy (SRT): Operates at 40-150 kVp, typically used for lesions within 5 mm of the skin surface.
- Orthovoltage Therapy: Operates at 150-500 kVp, used for deeper lesions up to 5 cm depth.
- Applications: Primarily used for BCC, SCC, keloids, and benign skin/musculoskeletal conditions, as well as for palliative care.
- Advantages: Convenient, often no anesthesia or stitches required, high cure rates, and superior cosmetic outcomes for face, ear, or scalp tumors.
- Treatment Plan: Sessions are quick, usually lasting less than 15 minutes, with multiple, small daily treatments often recommended.
Radiant Aura
The Gold Standard for Aesthetic Radiotherapy
The Radiant Aura system represents a paradigm shift in the non-surgical treatment of non-melanoma skin cancer (NMSC) and keloid scarring. Specifically tailored for modern dermatology practices and aesthetic clinics, this platform merges clinical potency with superior cosmetic outcomes. Its streamlined, patient-friendly design allows for precise radiation delivery in a comfortable setting, minimizing the risks associated with invasive surgery. For patients concerned with scarring on visible areas like the face or neck, Radiant Aura offers a gentle yet highly effective therapeutic alternative.
Xstrahl 100
Specialized Care for Superficial Lesions
The Xstrahl 100 is a dedicated superficial radiotherapy unit designed to address malignancies located on or just beneath the skin’s surface. It is a primary tool for treating basal cell carcinomas, squamous cell carcinomas, and various benign skin disorders. By utilizing low-energy X-rays, the system concentrates the maximum radiation dose at the surface level, effectively sparing the healthy, deeper tissues beneath. Its ergonomic maneuverability ensures that clinicians can treat difficult anatomical sites with ease and precision.
Xstrahl 150
A Versatile Bridge for Diverse Clinical Needs
Offering a broader energy spectrum, the Xstrahl 150 serves as a versatile bridge between superficial and orthovoltage therapy. This system provides the increased penetration power necessary to treat thicker or slightly deeper skin tumors that a standard superficial unit might not reach. Equipped with a comprehensive set of clinical applicators, the Xstrahl 150 allows medical teams to fine-tune the radiation beam, making it an essential multipurpose asset for oncology departments managing a diverse patient workload.
Xstrahl 200
Comprehensive Orthovoltage and Palliative Support
The Xstrahl 200 is a high-capacity orthovoltage system engineered to expand the scope of radiotherapy into palliative care and the treatment of deeper benign pathologies. It is frequently utilized for managing secondary bone metastases, providing significant pain relief and improved quality of life for patients. Additionally, its higher energy range is highly effective for treating degenerative inflammatory conditions, such as painful joint disorders, making it a cornerstone of comprehensive radiation oncology.
Xstrahl 300
The Ultimate Powerhouse in Orthovoltage Technology
As the most advanced and powerful system in the Xstrahl clinical portfolio, the Xstrahl 300 offers an unparalleled range of treatment depths. This unit is the definitive “all-in-one” solution, capable of performing everything from delicate superficial skin treatments to deep-seated orthovoltage therapy for palliative cases. Its flexibility allows hospitals to consolidate their radiation services into a single, highly efficient platform. The Xstrahl 300 ensures clinical excellence through sophisticated dose control and over two decades of proven engineering reliability.
How to choose your system?
| Clinical Applications | |||||
|---|---|---|---|---|---|
| Condition | Radiant | Xstrahl 100 | Xstrahl 150 | Xstrahl 200 | Xstrahl 300 |
| Superficial Therapy | |||||
| Basal Cell Carcinoma (BCC) | ✓ | ✓ | ✓ | ✓ | ✓ |
| Squamous Cell Carcinoma (SCC) | ✓ | ✓ | ✓ | ✓ | ✓ |
| Bowen’s Disease | ✓ | ✓ | ✓ | ✓ | ✓ |
| Merkel Cell Carcinoma | ✓ | ✓ | ✓ | ||
| Lentigo Maligna | ✓ | ✓ | |||
| Mycosis Fungoides | ✓ | ✓ | ✓ | ✓ | |
| Benign Conditions | |||||
| Keloid Scars | ✓ | ✓ | ✓ | ✓ | ✓ |
| Morbus Ledderhose | ✓ | ✓ | ✓ | ||
| Dupuytren’s Contracture | ✓ | ✓ | ✓ | ||
| Palliative Care | |||||
| Soft Tissue Metastases | ✓ | ✓ | |||
| Bony Metastases | ✓ | ✓ | |||